AFC HD AMS Life Science Co (TSE:2927) EBIT: 円2,262 Mil (TTM As of Feb. 2026)


TSE:2927 AFC HD AMS Life Science Co Ltd TSE:2927
70 GF Score
Price 円861.00
GF Value 円997.83
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is AFC HD AMS Life Science Co EBIT?

AFC HD AMS Life Science Co TSE:2927 +0.23% 70 EBIT is 円2,262 Mil as of Feb. 2026. GuruFocus rates TSE:2927 with a GF Score™ of 70/100 and a GF Value™ of 円997.83 (Modestly Undervalued). The stock has 6 warning signs investors should review.

AFC HD AMS Life Science Co's earnings before interest and taxes (EBIT) for the six months ended in Feb. 2026 was 円1,332 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2026 was 円2,262 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. AFC HD AMS Life Science Co's annualized ROC % for the quarter that ended in Feb. 2026 was 3.37%. AFC HD AMS Life Science Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 10.59%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. AFC HD AMS Life Science Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 8.87%.

AFC HD AMS Life Science Co  (TSE:2927) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

AFC HD AMS Life Science Co's annualized ROC % for the quarter that ended in Feb. 2026 is calculated as:

ROC % (Q: Feb. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Aug. 2025 ) + Invested Capital (Q: Feb. 2026 ))/ count )
=2502.446 * ( 1 - 33.98% )/( (48295.73 + 49840.063)/ 2 )
=1652.1148492/49067.8965
=3.37 %

where

Invested Capital(Q: Aug. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=48726.913 - 4098.67 - ( 11303.492 - max(0, 25992.564 - 22325.077+11303.492))
=48295.73

Invested Capital(Q: Feb. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=50254.604 - 4347.88 - ( 11091.081 - max(0, 26612.123 - 22678.784+11091.081))
=49840.063

Note: The Operating Income data used here is two times the semi-annual (Feb. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

AFC HD AMS Life Science Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Aug. 2025  Q: Feb. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2664.488/( ( (21335.985 + max(3453.434, 0)) + (22289.326 + max(3243.401, 0)) )/ 2 )
=2664.488/( ( 24789.419 + 25532.727 )/ 2 )
=2664.488/25161.073
=10.59 %

where Working Capital is:

Working Capital(Q: Aug. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2930.063 + 7022.651 + 1055.794) - (4098.67 + 0 + 3456.404)
=3453.434

Working Capital(Q: Feb. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3221.355 + 7333.01 + 819.206) - (4347.88 + 0 + 3782.29)
=3243.401

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Feb. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

AFC HD AMS Life Science Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2026 )
=2261.638/25490.737
=8.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AFC HD AMS Life Science Co EBIT Related Terms

AFC HD AMS Life Science Co EBIT Historical Data

* Premium members only.

The historical data trend for AFC HD AMS Life Science Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AFC HD AMS Life Science Co EBIT Chart

AFC HD AMS Life Science Co Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,207.85 1,293.03 1,603.52 2,012.07 2,402.23

AFC HD AMS Life Science Co Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,073.29 938.79 1,472.83 929.39 1,332.24

TSE:2927 vs KHC, GIS: EBIT Comparison

For the Packaged Foods subindustry, AFC HD AMS Life Science Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AFC HD AMS Life Science Co EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, AFC HD AMS Life Science Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where AFC HD AMS Life Science Co's EV-to-EBIT falls into.


TSE:2927
70GF Score
AFC HD AMS Life Science Co Ltd TSE:2927
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AFC HD AMS Life Science Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円2,262 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円2,262 Mil mean?
AFC HD AMS Life Science Co (TSE:2927) has a EBIT of 円2,262 Mil as of Feb. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on AFC HD AMS Life Science Co.
Is AFC HD AMS Life Science Co's EBIT too high?
AFC HD AMS Life Science Co's current EBIT is 円2,262 Mil. Overall, AFC HD AMS Life Science Co has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AFC HD AMS Life Science Co's EBIT compare to KHC and GIS?
AFC HD AMS Life Science Co's EBIT of 円2,262 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on AFC HD AMS Life Science Co. AFC HD AMS Life Science Co's current EBIT is 円2,262 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFC HD AMS Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, AFC HD AMS Life Science Co (TSE:2927) is currently considered Modestly Undervalued. The stock's GF Value™ is 円997.83, compared to a current price of 円861.00 — trading 13.7% below its estimated fair value. The current EBIT is 円2,262 Mil. AFC HD AMS Life Science Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For AFC HD AMS Life Science Co (TSE:2927), the current EBIT is 円2,262 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AFC HD AMS Life Science Co (TSE:2927) Overvalued in 2026?

Based on GuruFocus' analysis, AFC HD AMS Life Science Co stock appears to be undervalued. The current stock price of 円861.00 is trading 13.7% below its estimated GF Value™ of 円997.83. GuruFocus considers AFC HD AMS Life Science Co to be Modestly Undervalued.

Key valuation signals for TSE:2927:

  • EBIT: 円2,262 Mil
  • GF Value™: 円997.83 vs. price of 円861.00 (13.7% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the TSE:2927 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AFC HD AMS Life Science Co Business Description

Address 3-6-36, Toyoda, Suruga-ku, Shizuoka Prefecture, Shizuoka, JPN, 422-8027
AFC HD AMS Life Science Co Ltd formerly AMS Life Science Co., Ltd is engaged in manufacturing and selling of health foods and cosmetics in Japan.
70GF Score

Get the complete analysis for TSE:2927

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円861.00
Price
円997.83
GF Value